NCT02258451
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02258451
Title Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Bayer
Indications
Therapies
Age Groups: adult
Covered Countries USA | POL | NOR | ITA | ISR | GBR | FRA | ESP | DEU | CHE | BEL | AUT

Facility Status City State Zip Country Details
La Jolla California 92093 United States Details
Los Angeles California 90033 United States Details
New Haven Connecticut 6510 United States Details
Hollywood Florida 33021 United States Details
Ashland Kentucky 41101 United States Details
Rockville Maryland 20850 United States Details
Ann Arbor Michigan 48109 United States Details
Detroit Michigan 48202 United States Details
Pontiac Michigan 48341 United States Details
Rochester Minnesota 55905 United States Details
St Louis Missouri 63110 United States Details
Newark New Jersey 07103 United States Details
Jamaica New York 11432 United States Details
Watertown South Dakota 57201 United States Details
Spokane Washington 99208-1129 United States Details
Innsbruck 6020 Austria Details
Brussels 1070 Belgium Details
Edegem 2650 Belgium Details
Kortrijk 8500 Belgium Details
Leuven 3000 Belgium Details
Angers 49055 France Details
Nantes 44805 France Details
Nîmes 30029 France Details
Saint-Cloud 92210 France Details
Tours 37044 France Details
Herne North Rhine-Westphalia 44625 Germany Details
Chai Wan Hong Kong Details
Hong Kong Hong Kong Details
Kowloon Hong Kong Details
Afula 1834111 Israel Details
Beersheba 8410101 Israel Details
Haifa 3109601 Israel Details
Holon 5822012 Israel Details
Jerusalem 9103102 Israel Details
Jerusalem 9112001 Israel Details
Ramat Gan 5262000 Israel Details
Tel Aviv 64239 Israel Details
Zrifin 7030000 Israel Details
Bari Apulia 70124 Italy Details
Bologna Emilia-Romagna 40138 Italy Details
Forlì Cesena Emilia-Romagna 47014 Italy Details
Modena Emilia-Romagna 41124 Italy Details
Rome Lazio 00149 Italy Details
Rome Lazio 00161 Italy Details
Genoa Liguria 16128 Italy Details
Cremona Lombardy 26100 Italy Details
Milan Lombardy 20132 Italy Details
Pisa Tuscany 56126 Italy Details
Nagoya Aichi-ken 464-8681 Japan Details
Sapporo Hokkaido 060-8648 Japan Details
Sayama Osaka 589-8511 Japan Details
Hidaka Saitama 350-1298 Japan Details
Kita-Adachigun Saitama 362-0806 Japan Details
Koto-ku Tokyo 135-8550 Japan Details
Kagoshima 892-0833 Japan Details
Osaka 540-0006 Japan Details
Oslo 0424 Norway Details
Bialystok 15-027 Poland Details
Gdansk 80-952 Poland Details
Gdynia 81-519 Poland Details
Poznan 61-485 Poland Details
Warsaw 02-781 Poland Details
Singapore 119074 Singapore Details
Singapore 168583 Singapore Details
Singapore 258499 Singapore Details
Suwon Gyeonggido 442-723 South Korea Details
Seoul Seoul Teugbyeolsi 03080 South Korea Details
Busan 49241 South Korea Details
Daegu 42601 South Korea Details
Incheon South Korea Details
Seoul 05505 South Korea Details
Palma de Mallorca Illes Baleares 07120 Spain Details
Barcelona 08023 Spain Details
Barcelona 08041 Spain Details
Barcelona 8036 Spain Details
Madrid 28033 Spain Details
Madrid 28041 Spain Details
Madrid 28046 Spain Details
Madrid 28050 Spain Details
Pamplona 31008 Spain Details
Seville 41013 Spain Details
Seville 41071 Spain Details
Aarau Canton of Aargau 5001 Switzerland Details
Kaohsiung City 813414 Taiwan Details
Taichung 40705 Taiwan Details
Taipei 114 Taiwan Details
Taipei Taiwan Details
Truro Cornwall TR1 3LJ United Kingdom Details
Plymouth Devon PL6 8DH United Kingdom Details
Nottingham Nottinghamshire NG5 1PB United Kingdom Details
Taunton Somerset TA1 5DA United Kingdom Details
Bristol BS2 8ED United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field